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Pulmonary  nodular  lymphoid  hyperplasia  (NLH)  is  a  term  first  suggested  by  Kradin  and  Mark  to  describe  one  or 
more  pulmonary  nodules  or  localized  lung  infiltrates  consisting  of  reactive  lymphoid  proliferation.  To  date,  there  have 
been  only  a  few  cases  of  pulmonary  NLH  reported  associated  with  autoimmune  disorders.  There  is  no  case  of  NLH 
associated  with  Sjögren's  syndrome  from  Korea  in  the  medical  literature.  A  56-year-old  woman  was  referred  to  our 
hospital  with  cough  productive  of  sputum  and  chest  tightness.  The  Computed  tomography  scans  of  the  chest  revealed 
multiple  and  well-defined  peribronchiolar  nodular  opacities.  A  video  assisted  thoracoscopic  surgery  (VATS)  biopsy  was 
performed  and  the  nodular  opacity  in  the  lung  parenchyma  was  pathologically  confirmed  as  NLH.  Through  meticulous 
review  of  patient's  record,  we  found  that  she  had  been  suffering  from  dry  eye  and  dry  mouth.  The  symptoms 
suggested  Sjögren's  syndrome,  which  was  confirmed  by  specific  laboratory  tests  including  the  Schirmer  test, 
anti-nuclear  antibody  and  anti-Ro/La  antibody.  The  patient  is  followed  regularly  and  has  no  further  progression  of 
symptoms.
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INTRODUCTION
Sjögren's  syndrome  is  a  chronic  inflammatory  autoimmune 
disease  that  is  characterized  by  lymphocytic  infiltration  of  the 
exocrine  glands  resulting  in  the  sicca  syndrome
1-3).  Several 
pulmonary  manifestations  associated  with  primary  Sjögren's 
syndrome  have  been  reported  such  as  airway  disease, 
interstitial  lung  disease,  alveolar  disease,  lymphoproliferative 
disease,  and  other  pleural  abnormalities
1, 3).  Although  variety  of 
lung  diseases  are  associated  with  Sjögren's  syndrome, 
lymphoma  or  pseudolymphoma  should  be  suspected  when  lung 
nodules  or  hilar  and/or  mediastinal  lymphadenopathy  are 
identified  on  chest  radiographs.  Pseudolymphoma  is  often 
considered  to  include  mucosa-associated  lymphoid  tissue 
(MALT)  lymphoma,  NLH  and  other  low-grade  lymphoid 
diseases
4, 5).  However,  the  differentiation  between  NLH  and 
other  entities  is  difficult.  Therefore,  surgical  biopsy  and 
immunohistochemical  evaluation  is  often  necessary
6).
  Here  we 
report  a  patient  with  biopsy  proven  pulmonary  NLH  associated 
with  Sjögren's  syndrome.
CASE REPORT
A  56-year-old  woman  presented  with  chest  tightness,  chronic 
cough  and  sputum  that  was  present  over  the  past  three  years. 
Her  symptoms  did  not  subside  with  medical  treatment  at  local 
hospitals.  The  patient  was  referred  to  our  hospital.  The  chest Moo-Kon  Song,  et  al  :  Pulmonary  NLH  Associated  with  Sjögren's  Syndrome 193
 
Figure  1.  Numerous  parenchymal  nodules  in  both  upper  lobe  lung  fields  (A)  and  irregular  thickening  of  the  right  major  fissure  (B).
 
Figure 2. Follow-up chest CT 2 months after the initial visit reveals peribronchial consolidation (A), and marked bronchial wall thickening 
(B)  in  the  right  middle  lobe  lung  field.
plain  radiograph  and  chest  CT  scan  showed  multiple  and 
relatively  well-defined,  multifocal  peribronchiolar  nodules  (Figure 
1).  There  were  no  contributory  findings  in  the  medical  and  social 
history. 
The  physical  examination  showed  a  blood  pressure  of  100/70 
mmHg  with  a  pulse  rate  of  78/min,  respiratory  rate  27/min,  body 
temperature  36.8℃.  The  patient  appeared  well.  The  sclera  was 
not  icteric,  the  abdomen  was  flat  and  there  were  no  gross 
abnormalities. 
Laboratory  findings  at  the  first  visit  showed:  the  blood  cell 
count  was  5,750/mm
3,  hemoglobin  12.7  g/dL,  hematocrit  37.3%, 
and  the  platelet  count  was  298,000/mm
3.  The  serum  biochemical 
findings  were  an  AST  of  20  IU/L,  ALT  13  IU/L,  ALP  182  IU/L, 
LDH  386  IU/L,  total  bilirubin  0.86  mg/dL,  direct  bilirubin  0.10 
mg/dL,  total  protein  7.9  g/dL,  albumin  4.0  g/dL,  BUN  15  mg/dL, 
creatinine  0.6  mg/dL,  total  cholesterol  184  mg/dL,  uric  acid  4.9 
mg/dL,  Ca  9.3  mg/dL,  P  4.4  mg/dL,  Na  140.8  mEq/L,  K  4.1 
mEq/L,  and  Cl  108.7  mEq/L. 
  The  pulmonary  function  testing  showed  a  normal  predicted 
value.  The  bronchoscopic  findings  were  not  specific.  Bacterial 
and  fungal  cultures  were  negative.  The  AFB  stain,  AFB  culture 
and  M.  tuberculosis  polymerase  chain  reaction  (RCR)  of  the 
bronchoscopic  washing  fluid  was  negative.  The  patient  was 
admitted  to  our  hospital  for  further  evaluation. 
  Follow-up  chest  CT  showed  similar  peribronchiolar  nodules; 
the  noted  consolidations  persisted  at  both  the  upper  and  middle 
lobes  of  the  lung  (Figure  2).  The 
18FDG-PET  CT  scan  showed 
mild  increased  uptake  consistent  with  glucose  metabolism  the 
peak  SUV  was  1.5  at  the  RUL  and  1.6  at  the  RML  (Figure  3). 
In  the  2  hour  delayed  views,  the  peak  SUV  was  1.6  at  the  RUL 
and  1.2  at  the  RML.  Percutaneous  CT-guided  needle  aspiration 
biopsy  was  performed  targeting  the  consolidation  area  in  the 
RML.  However,  the  biopsy  was  insufficient  for  a  diagnosis. 
Therefore,  a  VATS  biopsy  was  planned  of  the  consolidation 
area  in  the  RML. 
The  gross  appearance  of  the  involved  lung  appeared 
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Figure 3. 
18FDG PET-CT scan shows increased glucose metabolism and peribronchial consolidation in the right upper lobe (A) and middle 
lobe  (B).
 
Figure 4. The Hematoxylin-eosin stain showed peribronchiolar lymphocytic infiltration and bronchiolar damage (A, ×100), fibrotic narrowing 
is  seen  in  small  vessels  and  peribronchiolar  fibrosis  is  commonly  associated  with  lymphocytic  infiltration  (B,  ×200).
consolidated.  The  microscopic  findings  showed  that  the  alveolar 
walls  rather  than  the  air  spaces  were  affected;  they  were 
expanded  by  the  interstitial  infiltrate.  The  inflammatory  infiltrates 
were  prominent  around  the  bronchovascular  bundles  and 
formed  rounded  nodular  aggregates  around  small  intralobular 
vessels.  The  infiltrates  consisted  of  predominantly  small 
lymphocytic  cells  with  some  mixture  of  plasma  cells  and  a  few 
larger  mononuclear  cells.  Surrounding  parenchyma  occasionally 
revealed  lymphoid  follicles  (Figure  4).  Immunohistochemically, 
the  infiltrate  was  predominantly  composed  of  T  cells  (CD45RO 
positive);  there  were  only  focal  peribronchiolar  or  paraseptal 
collections  of  B  cells  (CD20  positive).  Molecular  studies  were 
performed  to  rule  out  MALT  lymphoma.  Amplification  of  the 
immunoglobulin  heavy  chain  gene  by  PCR  showed  a  polyclonal 
pattern  of  reactivity  (Figure  5).  The  pulmonary  nodular  opacities 
were  confirmed  as  nodular  lymphoid  hyperplasia  histologically.
We  investigated  the  possibility  of  an  association  between 
these  findings  and  connective  tissue  disease,  immunodeficiency 
conditions  or  hypersensitivity  reactions.  The  patient  had 
complained  of  mild  dry  eyes  and  mouth.  The  ANA  was  positive 
(1:640,  speckled  type),  and  the  anti-La  antibody  was  positive.  In 
addition,  the  Schirmer  test  was  positive.  The  findings  were 
consistent  with  the  diagnosis  of  Sjögren's  syndrome.  The  patient 
had  pulmonary  NLH  associated  with  Sjögren's  syndrome. 
Pilocarpine  was  prescribed  for  dry  eye.  The  patient  is  followed 
regularly  and  has  no  progressive  symptoms. 
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Figure  5.  In  the  immunoglobulin  heavy  chain  rearrangement 
analysis,  a  positive  control  with  a  monoclonal  immunoglobulin 
heavy  chain  pattern  of  a  lymphoma  patient.  The  heavy  chain 
rearrangement  in  our  patient  shows  a  polyclonal  pattern  of 
reactivity, different from the positive control (M: molecular marker, 
PC:  positive  control,  NC:  negative  control,  bp:  base  pair). 
DISCUSSION
Sjögren's  syndrome  is  an  autoimmune  disease  characterized 
by  keratoconjunctivitis  sicca  and  xerostomia
7).  Keratocon-
junctivitis  sicca  and  xerostomia  is  caused  by  lymphocytic 
infiltration  of  lacrimal  and  salivary  glands  and  associated 
pulmonary  findings  are  common.  The  frequency  of  lung 
involvement  in  patients  with  Sjögren's  syndrome  is  difficult  to 
ascertain  and  varies  according  to  criteria  used  for  the  diagnosis. 
The  pulmonary  manifestation  associated  with  Sjögren's 
syndrome  include  xerotrachea,  bronchial  sicca,  obstructive  small 
airway  disease,  interstitial  lung  diseases,  lymphoinfiltrative  or 
lymphoproliferative  lung  diseases,  and  other  pleural 
abnormalities
8, 9).  Lymphoinfiltrative  or  lymphoproliferative  lung 
diseases  include  follicular  bronchiolitis,  pseudolymphoma  and 
lymphoma,  as  well  as  lymphocytic  interstitial  pneumonia. 
Differentiation  of  these  lung  diseases  is  difficult.  Therefore, 
surgical  confirmation  is  necessary
6). 
Pathologically,  pseudolymphoma  is  characterized  by  infiltra-
tion  of  mature  lymphocytes  and  plasma  cells  without 
involvement  of  lymph  nodes
10).  Reactive  follicles  and  germinal 
centers  are  present  within  the  lesion.  However,  it  is  difficult  to 
determine  whether  these  findings  are  due  to  a  benign  reactive 
hyperplasia  or  a  malignancy.  The  findings  of  morphologically 
low-grade  lymphoid  proliferation  with  reactive  germinal  centers 
in  the  lung  may  represent  low-grade  B  cell  lymphomas  of 
MALT
5).  Immunohistochemical  studies  can  be  used  to  help 
differentiate  the  etiology  of  these  findings.  NLH  is  considered  a 
benign  lesion  composed  of  polyclonal  lymphocytes.  However, 
MALT  lymphoma  is  consists  of  monoclonal  lymphocytes
4, 5, 10). 
Pseudolymphoma  includes  MALT  lymphoma,  NLH  and  other 
low-grade  lymphoproliferative  diseases
4, 5). 
NLH  can  be  found  in  any  age  group,  but  the  majority  of 
cases  occur  between  ages  50  and  69.  Abbondanzo  et  al 
reported  14  cases  with  a  slight  female  predominance  and 
median  age  of  65  years  (range  19-80)
5).  Most  patients  are 
asymptomatic  but  some  present  with  cough,  sputum  or 
dyspnea
4).  Association  with  autoimmune  disorders  such  as 
Sjögren's  syndrome  has  been  suggested  in  some  cases. 
However,  there  is  no  previous  case  reported  in  Korea
11). 
The  most  frequent  radiographic  finding  of  NLH  is  a  solitary 
pulmonary  nodule.  The  chest  x-ray  in  approximately  65%  of 
cases  of  nodular  lymphoid  hyperplasia  shows  a  solitary  nodule 
that  typically  measures  2  to  4  cm  in  diameter
12).  Multiple  lesions 
have  been  reported  in  36%  of  patients
5).  Abnormal  lesions  on 
the  chest  radiograph,  are  either  discrete  nodules  or  ill-defined 
nodular  opacities.  Air-bronchograms  are  often  noted.  On  CT 
scan,  lesions  are  discrete  pulmonary  nodules  or  ill-defined 
nodular  opacities  associated  with  air-bronchograms  and 
vascular  involvement
2, 11). 
NLH  of  the  lung  has  several  constant  pathological  features. 
Most  cases  are  solitary,  but  two  or  three  nodules  may  be 
present.  The  lesion  is  characterized  by  circumscribed  masses  of 
lymphoid  tissue  with  numerous  reactive  germinal  centers
6, 12). 
The  germinal  centers  typically  have  well  preserved  mantle 
zones  and  plasma  cells  prominent  within  their  interfollicular 
areas.  Immunohistochemical  analysis  shows  a  mixture  of  B  and 
T  cells  with  germinal  centers  expressing  CD20  (B  cell  type)  and 
interfollicular  lymphocytes  expressing  CD3,  CD43  and  CD5  (T 
cell  type).  A  polyclonal  pattern  of  reactivity  on  immuno-
histochemical  staining  is  consistent  with  the  diagnosis  of  NLH
6). 
  In  our  case,  the  patient  was  referred  to  our  hospital  due  to 
mild  respiratory  symptoms  and  abnormal  radiological  findings 
including  bronchial  wall  thickening,  irregular  peribronchial 
consolidation  and  multiple  ill-defined  nodules  in  both  lung  fields. 
VATS  was  performed  and  part  of  the  lesion  resected.  A  reactive 
lymphoid  follicle  with  germinal  centers  was  noted,  but 
lymphoepithelial  reaction  was  not  seen  on  pathology.  The 
immunohistochemical  studies  showed  mixed  cells  with  germinal 
centers  and  a  polyclonal  cell  pattern,  this  confirmed  the 
diagnosis  of  NLH.  The  patient  is  doing  well  with  no  further 
clinical  manifestations. 
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